Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus

OBJECTIVES: Patients with systemic lupus erythematosus (SLE) are usually treated with glucocorticosteroids even during periods of clinically quiescent disease. A recent study showed that abrupt glucocorticoid withdrawal was associated with an increased likelihood of flare in the next 12 months. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Tselios, Konstantinos, Gladman, Dafna D., Su, Jiandong, Urowitz, Murray B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363847/
https://www.ncbi.nlm.nih.gov/pubmed/34245233
http://dx.doi.org/10.1002/acr2.11267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363847/
https://www.ncbi.nlm.nih.gov/pubmed/34245233
http://dx.doi.org/10.1002/acr2.11267

Ejemplares similares